Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.

Mann MJ, Gibbons GH, Hutchinson H, Poston RS, Hoyt EG, Robbins RC, Dzau VJ.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6411-6.

2.

Development of antisense oligodeoxynucleotides for transplantation.

Stepkowski SM.

Curr Opin Mol Ther. 2000 Jun;2(3):304-17. Review.

PMID:
11249625
3.

Gene therapy for arthritis.

Tomita T, Hashimoto H, Yoshikawa H.

Curr Drug Targets. 2003 Nov;4(8):609-12. Review.

PMID:
14577650
4.

The mechanism of naked DNA uptake and expression.

Wolff JA, Budker V.

Adv Genet. 2005;54:3-20. Review.

PMID:
16096005
5.

Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.

Morishita R, Kaneda Y, Ogihara T.

BioDrugs. 2003;17(6):383-9. Review.

PMID:
14614761
6.

Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?

Morishita R, Aoki M, Kaneda Y.

Curr Drug Targets. 2000 Jul;1(1):15-23. Review.

PMID:
11475534
7.

[Oligonucleotide-based therapy as a potential new pharmacotherapy].

Morishita R.

Nihon Yakurigaku Zasshi. 2000 Mar;115(3):123-30. Review. Japanese.

PMID:
10876797
8.

Designing antisense to inhibit the renin-angiotensin system.

Mohuczy D, Phillips MI.

Mol Cell Biochem. 2000 Sep;212(1-2):145-53. Review.

PMID:
11108146
9.

mRNA as gene therapeutic: how to control protein expression.

Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman J.

J Control Release. 2011 Mar 30;150(3):238-47. doi: 10.1016/j.jconrel.2010.10.020. Epub 2010 Oct 21. Review.

PMID:
20970469
Items per page

Supplemental Content

Write to the Help Desk